Cite
HARVARD Citation
Kudo, M. et al. (n.d.). Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial. Hepatology. 60 (5), pp. 1697-1707. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kudo, M. et al. (n.d.). Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial. Hepatology. 60 (5), pp. 1697-1707. [Online].